FTC Imposes Conditions on AbbVie Inc.’s Acquisition of Allergan plc
Date
Pharmaceutical companies AbbVie Inc. and Allergan plc have agreed to divest assets to settle Federal Trade Commission charges that AbbVie’s proposed $63 billion acquisition of Allergan would violate...